By now, GLP-1 medications have become part of the everyday conversation around weight loss and metabolic health, but new research suggests they may be doing more behind the scenes. As reported in Medscape, researchers shared findings at the American Academy of Allergy, Asthma & Immunology 2026 Annual Meeting that point to a surprising benefit: fewer asthma attacks.
The study looked at more than 3,000 adults with overweight or obesity and tracked asthma flare-ups over a three-year period. Some patients were taking a GLP-1 medication, while others were not. Across the board, those using GLP-1s saw a reduction in exacerbations, with risk dropping by about 12 to 15 percent.
According to Rutgers New Jersey Medical School internal medicine resident and study author Ruchi Patel, MD, the numbers translate clearly in real-world terms. “That’s 12 to 15 fewer exacerbations per 100 patients that are treated with the GLP-1,” she shared in an interview with HCPLive.
Why It’s Helping
Inflammation is likely part of the story. “It’s probably a bit of both,” Dr. Patel explained, pointing to both weight loss and anti-inflammatory effects. “The reason why I think it’s not just weight loss is because even in our overweight category, their results stayed pretty consistent. That makes me think it’s also the anti-inflammatory effects of the GLP-1.”
Obesity has long been linked to worse asthma outcomes, but treatments that address both metabolic health and airway inflammation are limited. Dr. Patel also noted that while many primary care providers are already familiar with GLP-1s, specialists may need to be more proactive. “If the patient comes to a specialist and it hasn’t been brought up yet, it’s a really good thing to bring up,” she said.
What to Know
GLP-1 medications are not approved to treat asthma, and this study does not change that. The research is observational, meaning it shows a connection but does not prove cause and effect. Larger, controlled trials are still needed.
Still, the findings add another layer to a category that continues to expand beyond weight loss. For patients managing both asthma and excess weight, it may open the door to a more comprehensive conversation with their doctor and how these medications may fit into a broader treatment plan.
